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aBstraCt
Posterior reversible encephalopathy syndrome (PRES) is a poorly understood, severe neurological condition secon-
dary to impaired auto-regulation in the vertebrobasilar brain circulation resulting in subcortical vasogenic oedema 
distributed mainly in the white mater of the parietal and occipital lobes. Affecting optic radiation, PRES leads to 
visual deterioration, e.g. blurred vision, different types of vision field deficits, or even total blindness. The symptoms 
have a sudden onset and rapid progression, but are usually at least partially reversible. To bring this rare disorder 
closer to ophthalmologists, we present two cases of patients diagnosed with PRES.
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introduCtion
Patients with vision deterioration of sudden onset 
and fast progression need immediate management, 
including neuro-ophthalmological assessment. One 
of the possible causes of this condition is posterior 
reversible encephalopathy syndrome (PRES). Poste-
rior reversible encephalopathy syndrome (PRES) is 
a poorly understood, severe neurological condition 
secondary to impaired auto-regulation in the ver-
tebrobasilar brain circulation, resulting in subcor-
tical vasogenic oedema distributed mainly in the 
white mater of the parietal and occipital lobes. In 
PRES, the development of vasogenic cerebral oede-
ma affecting the white matter in the occipital and 
parietal lobes is essential [1]. It has various clinical 
manifestations, including severe headache, altered 
mental status with disorientation, changes in the 
level of consciousness, or generalised seizures [2]. 
Due to the high predilection of pathological lesions 
to localise in the occipital lobe white matter (affect-
ing visual radiation), PRES manifests also as vision 
deterioration. To bring this condition closer to oph-
thalmologists, we introduce two cases of patients 
diagnosed with PRES.
Case presentation
Case 1
A 45-year-old woman with end-stage kidney dis-
ease secondary to glomerular nephritis (GN) was 
admitted to the Department of Neurology because 
of sudden-onset severe headache localised in the oc-
cipital area and rapidly progressing vision deteriora-
tion in both eyes (blurred vision). In physical exam-
ination, visual acuity of the right eye showed poor 
light perception, of the left eye — poor light percep-
tion, and the reaction of pupils to light was correct. 
Before admission, the patient was qualified to hae-
modialysis therapy for decreasing glomerular filtra-
tion rate resulting in hard-to-control hypertension 
(even using polytherapy with hypotensive drugs of 
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Figure 2. Patient 1 — result of ocular coherence tomography performed 8 weeks after an episode of posterior reversible encephalopathy 
syndrome (PRES) — increased peripapillary nerve fibre layer thickness in the right eye in the lower quadrant
Figure 1. Patient 1 — MR T2 tirm hyper-intensive lesions in cerebellum and occipital lobes
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Figure 3. Patient 1 — result of ocular coherence tomography of the macula performed 8 weeks after an episode of posterior reversible 
encephalopathy syndrome (PRES) — normal profile in both eyes
Figure 4. Patient 1 — visual field result of both eyes without abnormalities (examination performed after episode of PRES)
different mechanisms of action). MRI on admission 
revealed diffused hyper-intensive lesions in T2 and 
FLAIR (fluid-attenuated inversion recovery/FLAIR) 
sequences affecting the parieto-occipital brain 
cortex on both sides and the cerebellum (Fig. 1). 
During hospitalisation, her elevated blood pressure 
was normalised using continuous infusions of ura-
pidil and loop diuretics under fluid and electro-
lyte (sodium and potassium) balance control. After 
discharge from the Department of Neurology, the 
patient was sent for haemodialysis. Eight weeks after 
hospitalisation in the Department of Neurology, 
visual acuity of the right eye was 1.0 without correc-
tion, of the left eye — 0.8 without correction, and 
1.0 with stenopeic correction. Fundus examination 
showed features of hypertensive angiopathy. Optical 
coherence tomography (OCT) showed a thickened 
peripapillary nerve fibre layer (RNFL) in the right 
eye; macular  scans and visual field were normal 
(Figs. 2–4).
Case 2
A 70-year-old female patient with uncontrolled 
hypertension was admitted to the Department of 
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Figure 5. Patient 2 — MR T2 tirm hyper-intensive lesions in cerebellum and occipital lobes
Figure 6. Patient 2 — result of ocular coherence tomography of the macula performed 2 weeks after episode of posterior reversible en-
cephalopathy syndrome (PRES) — normal profile in both eyes
Neurology because of double eye total blindness, 
which occurred during hypertensive crisis. Routine 
CT did not reveal any structural brain patholo-
gies; since an early phase of ischaemic stroke was 
suspected (early radiological signs of parenchymal 
ischaemia can be visualised by basic CT usually after 
few hours), the decision was made to amplify CT 
neuroimaging using contrast scanning with an an-
giography protocol to confirm or exclude occlusion 
of the arteries supplying the brain areas responsible 
for vision. The main cerebral arteries, including the 
posterior cerebral arteries on both sides, were not 
found to be occluded. Magnetic resonance (MR) 
imaging performed on the next day demonstrated 
gauzy (not well separated from the surrounding) 
hyper-intensive lesions in T2 and FLAIR sequences 
(Fig. 5). Those areas were also characterised by mod-
erate water diffusion restriction (diffusion-weighted 
imaging — DWI, and apparent diffusion coefficient 
— ADC sequences). To achieve stepwise normalisa-
tion of elevated blood pressure, intravenous contin-
uous infusion of hypotensive drugs (urapidil) and 
intensification of oral hypotensive treatment were 
required. Next day the patient could see some light, 
and after two days of therapy she saw the profiles 
of individuals and objects. The fundus examination 
showed features of hypertensive angiopathy. Optic 
disk, blind spot, and retina were normal (Fig. 6–8). 
Follow-up MRI performed two weeks later showed 
complete reversion of pathological lesions.
During the control visit in the Department of 
General Ophthalmology, two weeks after hospital-
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Figure 7. Patient 1 — visual field result of both eyes without abnormalities (examination performered after episode of PRES)
Figure 8. Patient 2 — result of ocular coherence tomography performed 2 weeks after an episode of posterior reversible encephalopathy 
syndrome (PRES) — normal peripapillary retinal nerve fibre layer in both eyes
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isation, visual acuity of the right eye was 0.3 with 
correction, and of the left eye — 0.3 with correc-
tion. Only initial crystalline lens opacity and fea-
tures of hypertensive angiopathy were found. OCT 
and visual field did not show any changes. 
disCussion
Posterior reversible encephalopathy syndrome 
(PRES) is considered a consequence of vasogenic 
cerebral oedema affecting the white matter in the 
occipital and parietal lobes. It is likely to be caused 
by poor autonomic innervation of arteries in the 
posterior brain circulation, resulting in their dis-
adaptation to high systemic blood pressure. The 
unadjusted arteries allow the blood serum to soak 
into the brain parenchyma, called vasogenic oede-
ma. This pathological mechanism can occur during 
hypertensive crisis in primary and secondary hy-
pertension (connected with renal artery stenosis or 
end-stage kidney disease) or in pre-eclampsia [2, 4].
Another possible mechanism likely to lead to 
PRES in patients without elevated blood pressure 
is endothelial dysfunction. Highly specialised en-
dothelial lining cells produce many different sub-
stances responsible for smooth blood streaming 
inside the arteries. Some of them, like prostacy-
clin or nitrogen oxide, cause dilatation of arter-
ies. Endothelial damage-induced dysregulation can 
be caused by autoimmune diseases (including sys-
temic vasculitis, e.g. Takayasu`s arteritis), malignant 
neoplasm, sepsis with multi-organ dysfunction, or 
adverse reactions to drugs (especially immunosup-
pressants and chemotherapeutics) [2]. The causes of 
PRES are presented in Table 1.
Posterior reversible encephalopathy syndrome 
(PRES) has various clinical manifestations, includ-
ing severe headache, altered mental status with dis-
orientation, changes in the level of consciousness, 
or generalised seizures [2]. Since the pathological 
changes have a specific predilection for the brain 
structures supplied by the vertebrobasilar circula-
tion, posterior reversible encephalopathy syndrome 
usually (20–62.5%) results in different types of 
visual deterioration: blurred vision, visual neglect, 
various types of vision field deficits (homonymous 
hemianopia), or even total blindness [2]. In the 
presented cases, visual loss was severe during the 
episode, but it was reversible, and at the end of the 
follow-up visual acuity was quite good — results of 
visual field examination and peripapillary RNFL 
were normal.
Every patient presenting with characteristic 
symptoms should undergo urgent MRI. In posteri-
or reversible encephalopathy syndrome, MRI reveals 
the lesions that are hyperintensive in T2 and FLAIR 
sequences and localised in both sides (symmetrical-
ly) in occipital and posterior parts of parietal brain 
lobes [1, 2]. In most cases, the changes persist for 
a few weeks. After that time, when the oedema 
descends, the follow-up MRI should be negative 
(in contrast to ischaemic stroke). Ophthalmological 
examinations in the acute phase (the first few days) 
can reveal optic disc swelling (papilledema) and 
haemorrhagic effusions in the eye bottom. Electro-
encephalography (EEG) during seizure attacks ob-
viously shows epileptic-form patterns; during inter 
seizure intervals the basic electrical activity slows 
down to below normal.
Treatment depends on aetiology. The elevat-
ed blood pressure should be carefully treated us-
ing repeated slow doses or continuous infusion of 
short-lasting (easy to control effect) hypotensive 
drugs, e.g. labetalol or urapidil. If PRES is second-
ary to immunosuppressive therapy or chemother-
apy, changes in drugs should be considered. Seizures 
should be managed with anti-epileptic drugs. If 
properly diagnosed and treated, PRES can be re-
versible.
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TABLE 1. Disorders and conditions considered to induce posterior reversible encephalopathy syndrome 
(PRES)
Primary and secondary (connected with renal artery stenosis or end-stage kidney disease) hypertensive crisis
Autoimmune diseases including systemic vasculitis (e.g. Takayasu’s arteritis) and glomerular nephritis
Malignant neoplasm
Preeclampsia
Sheehan syndrome (pituitary gland infarct)
Sepsis with multi-organ dysfunction
Adverse drug reactions (especially immunosuppressant drugs)
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